PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
17.85%
Revenue growth exceeding 1.5x Technology median of 4.57%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
17.82%
Gross profit growth exceeding 1.5x Technology median of 6.09%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
23.29%
EBIT growth exceeding 1.5x Technology median of 9.69%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
31.03%
Operating income growth exceeding 1.5x Technology median of 10.18%. Joel Greenblatt would see if unique processes drive exceptional profitability.
-1.96%
Negative net income growth while Technology median is 10.41%. Seth Klarman would investigate factors dragging net income down.
-2.65%
Negative EPS growth while Technology median is 11.33%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-2.03%
Negative diluted EPS growth while Technology median is 11.11%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
0.11%
Share growth above Technology median by more than 2x. Jim Chanos would suspect over-dilution or repeated equity raises.
0.22%
Diluted share change of 0.22% while Technology median is zero. Walter Schloss might see a slight difference in equity issuance policy.
0.13%
Dividend growth of 0.13% while Technology median is flat. Walter Schloss might appreciate at least a modest improvement.
-16.10%
Negative OCF growth while Technology median is 0.00%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-18.43%
Negative FCF growth while Technology median is 0.00%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
31.77%
10Y revenue/share CAGR exceeding 1.5x Technology median of 15.29%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
23.77%
5Y revenue/share growth exceeding 1.5x Technology median of 9.68%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
-0.08%
Negative 3Y CAGR while Technology median is 2.97%. Seth Klarman would examine if the sector is otherwise stable, indicating a company-specific issue.
41.36%
OCF/share CAGR of 41.36% while Technology median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
13.88%
OCF/share CAGR of 13.88% while Technology median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
-9.71%
Negative 3Y OCF/share CAGR while Technology median is 0.00%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
103.37%
Net income/share CAGR exceeding 1.5x Technology median of 16.57% over a decade. Joel Greenblatt might see a standout compounder of earnings.
88.52%
5Y net income/share CAGR > 1.5x Technology median of 18.41%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
13.44%
3Y net income/share CAGR > 1.5x Technology median of 3.54%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
7.90%
Equity/share CAGR exceeding 1.5x Technology median of 2.92% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
-7.15%
Negative 5Y equity/share growth while Technology median is 6.46%. Seth Klarman suspects firm-specific weaknesses if peers grow equity mid-term.
-18.37%
Negative 3Y equity/share growth while Technology median is 4.39%. Seth Klarman sees a short-term weakness if peers still expand net worth.
644.90%
Dividend/share CAGR of 644.90% while Technology is zero. Walter Schloss sees a minor improvement that could compound if the firm maintains consistent raises.
163.60%
5Y dividend/share CAGR of 163.60% while Technology is zero. Walter Schloss sees at least some improvement that could compound over time.
79.57%
3Y dividend/share CAGR of 79.57% while Technology is zero. Walter Schloss sees a slight advantage if the firm is at least inching up payouts.
18.37%
AR growth of 18.37% while Technology median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
-3.00%
Decreasing inventory while Technology is rising. Seth Klarman might see an efficiency advantage or possibly a sign of weaker sales future.
4.37%
Asset growth exceeding 1.5x Technology median of 0.66%. Joel Greenblatt confirms strong expansions matched by adequate returns on those assets.
8.79%
BV/share growth exceeding 1.5x Technology median. Joel Greenblatt checks if consistent ROE or undervalued buybacks fuel this advantage.
0.01%
Debt growth of 0.01% while Technology median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
1.85%
R&D growth of 1.85% while Technology median is zero. Walter Schloss wonders if a slight increase yields a meaningful competitive edge.
1.50%
SG&A growth far above Technology median. Jim Chanos sees potential red flags in cost management or diminishing returns on spending.